Grand View Research.com has announced the addition of Hemostasis Analyzers Market Analysis And Segment Forecasts To 2022 Market Research report to their Database.

More information: Hemostasis Analyzers

Increasing prevalence of chronic diseases coupled with growing incidences of blood clotting disorders are anticipated to propel the global hemostasis analyzers market over the forecast period. Hemostasis analyzers are components which helps in preventing excess blood lose during surgeries by changing the liquid blood into gel. Introduction of high throughput hemostasis analyzers are expected to result in revolutionary changes in hemostasis analyzers market over the forecast period. Increasing geriatric population base, technological advancement in technology and growing adoption of automated hemostasis instruments are the major drivers of this market. Furthermore, growing awareness campaigns by government, rising disposable income and increasing demand for advanced medical treatments are expected to expand the market over the next decade. Increasing innovation in laboratories automation coupled with favorable governmental policies are likely to drive the global hemostasis analyzers market.

In 2014, hemostasis analyzer for Point-Of-Care (POC) testing market is expected to witness significant growth in coming seven years due to increasing demand for automated hemostasis analyzers for medical diagnosis. Mechanical hemostasis analyzer market is anticipated to witness lucrative growth by 2022 owing to more accurate, sophisticated, and efficient management at a lower cost. Along with mechanical hemostasis analyzer, electrochemical, optical and other hemostasis analyzers are also expected to witness significant growth over the forecast period. By test type, D dimer test is likely to show high growth due to it provides complete picture of patient’s hemostasis function. Adoptions of latest technology coupled with heavy budgetary expenditure are the prime reason for the growth of hospital and research segment over the forecast period.
In 2014, North America held the largest market share owing to rapid advancement in technology, increasing R&D expenditures and rising demand medical surgeries such as organ transplants. Rising prevalence of homostasis diseases is anticipated to continue North America’s dominance over the forecast period. Asia Pacific region is expected to show highest growth in coming few years due to increasing number of seminars and conferences conducted by governmental and non-governmental organizations.

Major market players are Sysmex Corporation, Siemens Healthcare, Nihon Kohden Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics, Alere Inc., International Technidyne Corporation and Instrumentation Laboratory Werfen Group.

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Website: www.grandviewresearch.com

Further information: Hemostasis Analyzers Market Trends 2015 To 2022 by Grand View Research, Inc. – visit www.pressreleaseplace.co.uk